Based on information available until September 2021, here are some factors that might influence the future of Semaglutide's active pharmaceutical ingredient:

1. Clinical Research and Expansion into Indications: Apart from treating type 2 diabetes, whether Semaglutide demonstrates potential efficacy in other medical areas like obesity, as well as its effects on different patient populations, will impact its future development.

2. Regulatory Approvals: Whether Semaglutide secures broader approvals from international regulatory agencies to expand its market reach will directly affect its future market performance.

3. Competitive Landscape: The pharmaceutical market is competitive, and the emergence of similar drugs as competitors could affect the market share and prospects of Semaglutide's active pharmaceutical ingredient.

4. New Treatment Methods and Technologies: With continuous advancements in medicine and technology, new treatment methods and technologies might emerge, influencing the utilization and demand for Semaglutide's active pharmaceutical ingredient.

5. Market Demand: The global diabetic patient population is continuously growing, which could positively impact the market demand for Semaglutide's active pharmaceutical ingredient.